Cargando…
Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses
PURPOSE: To evaluate quality of life (QoL) after post-prostatectomy intensity modulated radiation therapy (IMRT) in the “adjuvant” setting starting within 4 months of radical prostatectomy for adverse features; and “salvage” setting for a PSA≥0.2ng/mL. MATERIALS AND METHODS: Retrospective review of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557437/ https://www.ncbi.nlm.nih.gov/pubmed/28379660 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0189 |
_version_ | 1783257203577192448 |
---|---|
author | Abuodeh, Yazan A. Naghavi, Arash O. Juan, Tzu-Hua Ma, Zhenjun Wilder, Richard B. |
author_facet | Abuodeh, Yazan A. Naghavi, Arash O. Juan, Tzu-Hua Ma, Zhenjun Wilder, Richard B. |
author_sort | Abuodeh, Yazan A. |
collection | PubMed |
description | PURPOSE: To evaluate quality of life (QoL) after post-prostatectomy intensity modulated radiation therapy (IMRT) in the “adjuvant” setting starting within 4 months of radical prostatectomy for adverse features; and “salvage” setting for a PSA≥0.2ng/mL. MATERIALS AND METHODS: Retrospective review of 130 patients who underwent IMRT to the prostate bed±gold fiducial marker placement for image guidance to 64.8-72.0Gy (median, 70.2Gy) between 2004 and 2013. Higher doses were defined as 70.2-72.0Gy and lower doses were defined as 64.8-68.4Gy. Androgen deprivation therapy (ADT) was given to 4/48 (8%) adjuvant patients and 9/82 (11%) salvage patients. International Prostate Symptom Score (IPSS), Sexual Health Inventory for Men (SHIM), and Expanded Prostate Cancer Index Composite-26-bowel (EPIC-26-bowel) questionnaires were used to assess urinary, sexual, and bowel QoL, respectively. RESULTS: Median follow-up was 46 months. There were better urinary (p=0.03) and sexual (p=0.002) QoL scores with adjuvant IMRT relative to salvage IMRT. The use of prostate bed fiducial markers did not significantly affect urinary, sexual, or bowel QoL (p=0.39, p=0.49, and p=0.40, respectively). Higher total radiotherapy doses did not significantly affect urinary, sexual, or bowel QoL (p=0.21, p=0.61, and p=0.36, respectively). CONCLUSIONS: There was no significant change in urinary, sexual, and bowel sexual QoL with post-prostatectomy IMRT regardless of whether prostate bed fiducial markers or higher total radiotherapy doses were used. QoL with IMRT in the present study compares favorably with prior reports for three-dimensional conformal radiation therapy. |
format | Online Article Text |
id | pubmed-5557437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Sociedade Brasileira de Urologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-55574372017-08-30 Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses Abuodeh, Yazan A. Naghavi, Arash O. Juan, Tzu-Hua Ma, Zhenjun Wilder, Richard B. Int Braz J Urol Original Article PURPOSE: To evaluate quality of life (QoL) after post-prostatectomy intensity modulated radiation therapy (IMRT) in the “adjuvant” setting starting within 4 months of radical prostatectomy for adverse features; and “salvage” setting for a PSA≥0.2ng/mL. MATERIALS AND METHODS: Retrospective review of 130 patients who underwent IMRT to the prostate bed±gold fiducial marker placement for image guidance to 64.8-72.0Gy (median, 70.2Gy) between 2004 and 2013. Higher doses were defined as 70.2-72.0Gy and lower doses were defined as 64.8-68.4Gy. Androgen deprivation therapy (ADT) was given to 4/48 (8%) adjuvant patients and 9/82 (11%) salvage patients. International Prostate Symptom Score (IPSS), Sexual Health Inventory for Men (SHIM), and Expanded Prostate Cancer Index Composite-26-bowel (EPIC-26-bowel) questionnaires were used to assess urinary, sexual, and bowel QoL, respectively. RESULTS: Median follow-up was 46 months. There were better urinary (p=0.03) and sexual (p=0.002) QoL scores with adjuvant IMRT relative to salvage IMRT. The use of prostate bed fiducial markers did not significantly affect urinary, sexual, or bowel QoL (p=0.39, p=0.49, and p=0.40, respectively). Higher total radiotherapy doses did not significantly affect urinary, sexual, or bowel QoL (p=0.21, p=0.61, and p=0.36, respectively). CONCLUSIONS: There was no significant change in urinary, sexual, and bowel sexual QoL with post-prostatectomy IMRT regardless of whether prostate bed fiducial markers or higher total radiotherapy doses were used. QoL with IMRT in the present study compares favorably with prior reports for three-dimensional conformal radiation therapy. Sociedade Brasileira de Urologia 2017 /pmc/articles/PMC5557437/ /pubmed/28379660 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0189 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Abuodeh, Yazan A. Naghavi, Arash O. Juan, Tzu-Hua Ma, Zhenjun Wilder, Richard B. Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses |
title | Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses |
title_full | Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses |
title_fullStr | Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses |
title_full_unstemmed | Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses |
title_short | Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses |
title_sort | quality of life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557437/ https://www.ncbi.nlm.nih.gov/pubmed/28379660 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0189 |
work_keys_str_mv | AT abuodehyazana qualityoflifeafterpostprostatectomyintensitymodulatedradiationtherapytotheprostatebedwithorwithouttheuseofgoldfiducialmarkersforimageguidanceorhighertotalradiotherapydoses AT naghaviarasho qualityoflifeafterpostprostatectomyintensitymodulatedradiationtherapytotheprostatebedwithorwithouttheuseofgoldfiducialmarkersforimageguidanceorhighertotalradiotherapydoses AT juantzuhua qualityoflifeafterpostprostatectomyintensitymodulatedradiationtherapytotheprostatebedwithorwithouttheuseofgoldfiducialmarkersforimageguidanceorhighertotalradiotherapydoses AT mazhenjun qualityoflifeafterpostprostatectomyintensitymodulatedradiationtherapytotheprostatebedwithorwithouttheuseofgoldfiducialmarkersforimageguidanceorhighertotalradiotherapydoses AT wilderrichardb qualityoflifeafterpostprostatectomyintensitymodulatedradiationtherapytotheprostatebedwithorwithouttheuseofgoldfiducialmarkersforimageguidanceorhighertotalradiotherapydoses |